The impact of patients’ preferences on the decision of low-dose computed tomography lung cancer screening

Lung cancer is the 2^nd most common cancer diagnosis by gender, behind prostate cancer for men and breast cancer for women in the US. At present, the general prognosis of lung cancer is poor, as close to 50–70% of lung cancers are diagnosed in advanced stages without screening (1,2).